84 related articles for article (PubMed ID: 23055311)
1. IgG anti-Galnac-GD1a antibodies bind to neuromuscular junctions of rat hemidiaphragm.
Nagaoka T; Hotta S; Chiba T; Utsunomiya I; Abe K; Yoshino H; Koshikawa C; Taguchi K
Muscle Nerve; 2012 Nov; 46(5):705-10. PubMed ID: 23055311
[TBL] [Abstract][Full Text] [Related]
2. Neurophysiological and immunohistochemical studies on Guillain-Barre syndrome with IgG anti-GalNAc-GD1a antibodies-effects on neuromuscular transmission.
Taguchi K; Ren J; Utsunomiya I; Aoyagi H; Fujita N; Ariga T; Miyatake T; Yoshino H
J Neurol Sci; 2004 Oct; 225(1-2):91-8. PubMed ID: 15465091
[TBL] [Abstract][Full Text] [Related]
3. GalNAc-GD1a in human peripheral nerve: target sites of anti-ganglioside antibody.
Kaida K; Kusunoki S; Kamakura K; Motoyoshi K; Kanazawa I
Neurology; 2003 Aug; 61(4):465-70. PubMed ID: 12939418
[TBL] [Abstract][Full Text] [Related]
4. Identification of gangliosides recognized by IgG anti-GalNAc-GD1a antibodies in bovine spinal motor neurons and motor nerves.
Yoshino H; Ariga T; Suzuki A; Yu RK; Miyatake T
Brain Res; 2008 Aug; 1227():216-20. PubMed ID: 18598683
[TBL] [Abstract][Full Text] [Related]
5. GalNAc-GD1a is localized specifically in ventral spinal roots, but not in dorsal spinal roots.
Yoshino H; Utsunomiya I; Taguchi K; Ariga T; Nagaoka T; Aoyagi H; Asano A; Yamada M; Miyatake T
Brain Res; 2005 Sep; 1057(1-2):177-80. PubMed ID: 16154116
[TBL] [Abstract][Full Text] [Related]
6. IgG anti-GalNAc-GD1a antibody inhibits the voltage-dependent calcium channel currents in PC12 pheochromocytoma cells.
Nakatani Y; Nagaoka T; Hotta S; Utsunomiya I; Yoshino H; Miyatake T; Hoshi K; Taguchi K
Exp Neurol; 2007 Mar; 204(1):380-6. PubMed ID: 17234185
[TBL] [Abstract][Full Text] [Related]
7. Ataxic Guillain-Barré syndrome associated with anti-GM1b and anti-GalNAc-GD1a antibodies.
Odaka M; Yuki N; Tatsumoto M; Tateno M; Hirata K
J Neurol; 2004 Jan; 251(1):24-9. PubMed ID: 14999485
[TBL] [Abstract][Full Text] [Related]
8. Harmful effects of anti-GalNAc-GD1a antibodies and TNF-alpha on rat dorsal root ganglia.
Kamakura K; Kaida K; Kusunoki S; Miyamoto N; Masaki T; Nakamura R; Motoyoshi K; Fukuda J
J Peripher Nerv Syst; 2005 Jun; 10(2):190-201. PubMed ID: 15958130
[TBL] [Abstract][Full Text] [Related]
9. Neurophysiological and immunohistochemical studies of IgG anti-GM1 monoclonal antibody on neuromuscular transmission: effects in rat neuromuscular junctions.
Hotta S; Nagaoka T; Taguchi K; Nakatani Y; Utsnomiya I; Masuda Y; Abe K; Yuki N
Neurol Sci; 2014 Feb; 35(2):205-13. PubMed ID: 23820959
[TBL] [Abstract][Full Text] [Related]
10. Spectrum of neurological diseases associated with antibodies to minor gangliosides GM1b and GalNAc-GD1a.
Tatsumoto M; Koga M; Gilbert M; Odaka M; Hirata K; Kuwabara S; Yuki N
J Neuroimmunol; 2006 Aug; 177(1-2):201-8. PubMed ID: 16844234
[TBL] [Abstract][Full Text] [Related]
11. GM1/GalNAc-GD1a complex: a target for pure motor Guillain-Barre syndrome.
Kaida K; Sonoo M; Ogawa G; Kamakura K; Ueda-Sada M; Arita M; Motoyoshi K; Kusunoki S
Neurology; 2008 Nov; 71(21):1683-90. PubMed ID: 19015484
[TBL] [Abstract][Full Text] [Related]
12. Anti-ganglioside antibodies alter presynaptic release and calcium influx.
Buchwald B; Zhang G; Vogt-Eisele AK; Zhang W; Ahangari R; Griffin JW; Hatt H; Toyka KV; Sheikh KA
Neurobiol Dis; 2007 Oct; 28(1):113-21. PubMed ID: 17720506
[TBL] [Abstract][Full Text] [Related]
13. Anti-GalNAc-GD1a antibody-associated Guillain-Barré syndrome with a predominantly distal weakness without cranial nerve impairment and sensory disturbance.
Hao Q; Saida T; Yoshino H; Kuroki S; Nukina M; Saida K
Ann Neurol; 1999 Jun; 45(6):758-68. PubMed ID: 10360768
[TBL] [Abstract][Full Text] [Related]
14. Immunoglobulin G-class mouse monoclonal antibodies to major brain gangliosides.
Schnaar RL; Fromholt SE; Gong Y; Vyas AA; Laroy W; Wayman DM; Heffer-Lauc M; Ito H; Ishida H; Kiso M; Griffin JW; Shiekh KA
Anal Biochem; 2002 Mar; 302(2):276-84. PubMed ID: 11878808
[TBL] [Abstract][Full Text] [Related]
15. GD1b-specific antibody induces ataxia in Guillain-Barre syndrome.
Kaida K; Kamakura K; Ogawa G; Ueda M; Motoyoshi K; Arita M; Kusunoki S
Neurology; 2008 Jul; 71(3):196-201. PubMed ID: 18625966
[TBL] [Abstract][Full Text] [Related]
16. [Clinical features of neuropathies in a group of patients associated with anti-GalNAc-GD1a antibody].
Tatsumoto M; Odaka M; Koga M; Hirata K; Yuki N
Rinsho Shinkeigaku; 2004 Aug; 44(8):508-12. PubMed ID: 15471085
[TBL] [Abstract][Full Text] [Related]
17. Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction.
Cole RN; Reddel SW; Gervásio OL; Phillips WD
Ann Neurol; 2008 Jun; 63(6):782-9. PubMed ID: 18384168
[TBL] [Abstract][Full Text] [Related]
18. Severe sensory ataxia and demyelinating polyneuropathy with IgM anti-GM2 and GalNAc-GD1A antibodies.
Lopate G; Choksi R; Pestronk A
Muscle Nerve; 2002 Jun; 25(6):828-36. PubMed ID: 12115971
[TBL] [Abstract][Full Text] [Related]
19. Serum anti-GM2 and anti-GalNAc-GD1a ganglioside IgG antibodies are biomarkers for immune-mediated polyneuropathies in cats.
Halstead SK; Jackson M; Bianchi E; Rupp S; Granger N; Menchetti M; Galli G; Freeman P; Kaczmarska A; Bhatti SFM; Brocal J; José-López R; Tipold A; Gutierrez Quintana R; Ives EJ; Liatis T; Nessler J; Rusbridge C; Willison HJ; Rupp A
J Peripher Nerv Syst; 2023 Mar; 28(1):32-40. PubMed ID: 36573790
[TBL] [Abstract][Full Text] [Related]
20. High-affinity anti-ganglioside IgG antibodies raised in complex ganglioside knockout mice: reexamination of GD1a immunolocalization.
Lunn MP; Johnson LA; Fromholt SE; Itonori S; Huang J; Vyas AA; Hildreth JE; Griffin JW; Schnaar RL; Sheikh KA
J Neurochem; 2000 Jul; 75(1):404-12. PubMed ID: 10854286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
